Because it has been confirmed that BCL11A plays an important role in the silencing of γ-globin, many scientists have focused on restoring γ-globin expression by eliminating or downregulating BCL11A expression to treat β-hemoglobinopathies such as β-thalassemia and SCD. Here, BCL11A is linked to Schnyder corneal dystrophy.